Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administrationPaul Thoueille, Susana Alves Saldanha, Vincent Desfontaine, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
Open Forum Infectious Diseases|January 8, 2020
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIVPerrine Courlet, Françoise Livio, Monia Guidi, et al.
British Journal of Clinical Pharmacology|May 31, 2019
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainmentPerrine Courlet, Monia Guidi, Anaïs Glatard, et al.
Clinical Pharmacokinetics|October 30, 2020
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIVPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
Journal of Mass Spectrometry : JMS|March 12, 2020
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIVPerrine Courlet, Susana Alves Saldanha, Matthias Cavassini, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2019
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life settingCatalina Barcelo, Manel Aouri, Perrine Courlet, et al.
Nature Medicine|July 31, 2025
Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trialScott Kopetz, Valentina Boni, Ken Kato, et al.
JCO Clinical Cancer Informatics|May 5, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography ImagingDaniel Abler, Perrine Courlet, Matthieu Dietz, et al.
Pageof 3